Skip to main content
Log in

Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Previously, we showed that androgens stimulate murine and human osteoblast-like cell proliferation and differentiation by mechanisms involving increased responses to mitogenic growth factors (GF) and increased GF production. To explain this dual action of androgens on primary osteoblastic cell populations we advanced the hypothesis that androgens exert differential effects on osteoblastic subpopulations. We subcloned a human osteosarcoma cell line (SaOS2) into subpopulations expressing high (HAS) and low (LAS) levels of alkaline phosphatase (ALP). The obtained subclones differed significantly in their ALP production and expressed a high and low ALP phenotype, respectively, for the entire experimental period. Dihydrotestosterone (DHT) increased specific ALP activity and type-I procollagen peptide secretion in both HAS and LAS. DHT pretreatment enhanced the mitogenic action of basic fibroblast growth factor (bFGF) and insulinlike growth factor 2 (IGF2) only in HAS. The enhanced mitogenic effect of IGF2 in HAS after DHT pretreatment was associated with increased IGF2-receptor mRNA levels. Therefore, we conclude that androgens exert their osteoanabolic action (1) by stimulating differentiated functions of osteoblastic cells with a high and a low ALP phenotype, and (2) via increased growth factor receptor expression and thereby enhancing mitogenic growth factor responses only in HAS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Riggs BL (1987) Pathogenesis of osteoporosis. Am J Obstet Gynecol 156:1342–1346

    PubMed  CAS  Google Scholar 

  2. Stepan J, Lachman M, Zverina J, Pacovsky V, Baylink DJ (1989) Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523–527

    PubMed  CAS  Google Scholar 

  3. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal D, Segre G, Crowley WF (1989) Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69:776–783

    PubMed  CAS  Google Scholar 

  4. Wakley GK, Schutte HD, Hannon KS, Turner RT (1991) Androgen treatment prevents loss of cancellous bone in the orchiectomized rat. J Bone Miner Res 6:325–330

    PubMed  CAS  Google Scholar 

  5. Johansen JS, Hassager C, Podenphant J, Riis BJ, Hartwell D, Thomsen K, Christiansen C (1989) Treatment of postmenopausal osteoporosis: Is the anabolic steroid nandrolone decanoate a candidate? Bone Miner 6:77–86

    Article  PubMed  CAS  Google Scholar 

  6. Need AG, Horowitz M, Bridges A, Morris HA, Nordin BEC (1989) Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women. Arch Intern Med 149:57–60

    Article  PubMed  CAS  Google Scholar 

  7. Colvard CS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs LB, Spelsberg TC (1989) Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 86:854–857

    Article  PubMed  CAS  Google Scholar 

  8. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ (1989) Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124:1576–1578

    PubMed  CAS  Google Scholar 

  9. Farley JR, Baylink DJ (1986) Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism 35:563

    Article  PubMed  CAS  Google Scholar 

  10. Wlodarski KH, Reddi AH (1986) Alkaline phosphatase as a marker of osteoinductive cells. Calcif Tissue Int 39:382

    PubMed  CAS  Google Scholar 

  11. Murray E, Provendini D, Curran D, Catherwood B, Sussman H, Monolagas S (1987) Characterization of a human osteoblastic osteosarcoma cell line (SaOS2) with high bone alkaline phosphatase activity. J Bone Miner Res 2:231–238

    PubMed  CAS  Google Scholar 

  12. Farley JR, Kyeyune-Nyombi E, Tarbaux NM, Hall SL, Strong DD (1989) Alkaline phosphatase activity from human osteosarcoma cell line SaOS-2: an isoenzyme standard for quantifying skeletal alkaline phosphatase activity in serum. Clin Chem 35:223–229

    PubMed  CAS  Google Scholar 

  13. Orwoll ES, Stribrska L, Ramsey EE, Keenan EJ (1991) Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 49:183–187

    PubMed  CAS  Google Scholar 

  14. Bellows CG, Sodek J, Yao KL, Aubin JE (1986) Phenotypic differences in subclones and long-term cultures of clonally derived rat bone cell lines. J Cell Biochem 31:153–169

    Article  PubMed  CAS  Google Scholar 

  15. Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614–636

    Article  PubMed  CAS  Google Scholar 

  16. Kasperk CH, Fitzsimmons R, Strong D, Wergedal JE, Mohan S, Jennings J, Baylink DJ (1990) Studies on the mechanisms whereby androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 71:1322–1329

    PubMed  CAS  Google Scholar 

  17. Price PA (1983) Osteocalcin. In: Peck WA (ed) Bone and mineral research, annual I. Excerpta Medica, Amsterdam, Oxford, Princeton

    Google Scholar 

  18. Rodan GA, Rodan SB (1984) Expression of the osteoblastic phenotype, 244–285. In: Peck WA (Hrsg) Advances in bone and mineral research, annual 11. Excerpta Medica, Amsterdam, Oxford, Princeton

    Google Scholar 

  19. Parfitt AM, Simon LS, Villanueva AR (1987) Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. J Bone Miner Res 2:427–436

    PubMed  CAS  Google Scholar 

  20. Francini G, Gonelli S, Petrioli R, Bruni S, Marsili S, Aquino A, Camporeale A (1993) Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases. Cancer Epidemiol Biomarkers Prev 2:125–129

    PubMed  CAS  Google Scholar 

  21. Kasperk CH, Wergedal JE, Mohan S, Long D, Lau W, Baylink DJ (1990) Interactions of growth factors present in bone matrix on bone cell DNA synthesis and alkaline phosphatase. Growth Factors 3:147–158

    PubMed  CAS  Google Scholar 

  22. Wergedal JE, Mohan S, Lundy M, Baylink DJ (1990) Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 5:179–186

    PubMed  CAS  Google Scholar 

  23. Strong DD, Beachler AL, Wergedal JE, Linkhart TA (1991) Insulinlike growth factor II and transforming growth factor β regulate collagen expression in human osteoblastlike cells in vitro. J Bone Miner Res 6:15–23

    PubMed  CAS  Google Scholar 

  24. Whitson SW, Whitson MA, Bowers DE, Falk MC (1992) Factors influencing synthesis and mineralization of bone matrix from fetal bovine bone cells grown in vitro. J Bone Miner Res 7:727–741

    PubMed  CAS  Google Scholar 

  25. Beertsen W, van den Bos T (1992) Alkaline phosphatase induces the mineralization of sheets of collagen implanted subcutaneously in the rat. J Clin Invest 89:1974–1980

    Article  PubMed  CAS  Google Scholar 

  26. Farley JR, Hall SL, Herring S, Tarbaux NM, Matsuyama T, Wergedal JE (1991) Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS2. Metabolism 40:664–671

    Article  PubMed  CAS  Google Scholar 

  27. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990) Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of bone extracellular matrix. J Cell Physiol 143:420–430

    Article  PubMed  CAS  Google Scholar 

  28. Ibaraki K, Termine JD, Whitson SW, Young MF (1992) Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J Bone Miner Res 7:743–754

    PubMed  CAS  Google Scholar 

  29. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB (1990) Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143:312–321

    Article  Google Scholar 

  30. Weinreb M, Shinar D, Rodan GA (1990) Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 5:831–842

    Article  PubMed  CAS  Google Scholar 

  31. Kockx M, McCabe L, Stein JL, Stein GS (1994) Influence of DNA replication inhibition on expression of cell growth and tissue-specific genes in osteoblasts and osteosarcoma cells. J Cell Biochem 54:47–55

    Article  PubMed  CAS  Google Scholar 

  32. Fried A, Benayahu D, Wientroub S (1993) Marrow stroma-derived osteogenic clonal cell lines. J Cell Physiol 155:472–482

    Article  PubMed  CAS  Google Scholar 

  33. Rodan SB, Imai Y, Tiede MA, Wesolowski G, Thompson D, Bar Shavit Z, Shull S, Mann K, Rodan GA (1987) Characterization of a human osteosarcoma cell line (SaOS2) with osteoblastic properties. Cancer Res 47:4961–4966

    PubMed  CAS  Google Scholar 

  34. Feteih R, Tassinari MS, Lian JB (1990) Effect of sodium warfarin on vitamin K-dependent proteins and skeletal development in the rat fetus. J Bone Miner Res 5:885–894

    PubMed  CAS  Google Scholar 

  35. Vaishnav R, Beresford JN, Gallagher JA, Russell RGG (1988) Effects of the anabolic steroid stanozolol on cells derived from human bone. Clin Sci 74:455–460

    PubMed  CAS  Google Scholar 

  36. Stein GS, Lian JB, Owen TA (1990) Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111–3123

    PubMed  CAS  Google Scholar 

  37. Rao LG, Wylie JN, Sutherland MSK, Murray TM (1994) 17β-estradiol and parathyroid hormone potentiate each other's effects on alkaline phosphatase activity in SaOS2 cells in a differentiation-dependent manner. Endocrinology 134:614–620

    Article  PubMed  CAS  Google Scholar 

  38. Roholl PJM, Blauw E, Zurcher C, Dormans J, Theuns HM (1994) Evidence for a diminished maturation of preosteoblasts into osteoblasts during aging in rats: an ultrastructural analysis. J Bone Miner Res 9:355–366

    PubMed  CAS  Google Scholar 

  39. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277–286

    Article  PubMed  CAS  Google Scholar 

  40. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I (1994) Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218–228

    Article  PubMed  Google Scholar 

  41. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB (1991) Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype. Endocrinology 128: 1496–1504

    Article  PubMed  CAS  Google Scholar 

  42. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 162:156–159

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This paper is dedicated to the occasion of Prof. Dr. R. Ziegler's 60th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kasperk, C.H., Faehling, K., Börcsök, I. et al. Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2. Calcif Tissue Int 58, 376–382 (1996). https://doi.org/10.1007/BF02509388

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02509388

Key words

Navigation